Citadel Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-318,196
| Closed | -$37.7M | – | 15025 |
|
|
2021
Q1 | $37.7M | Buy |
318,196
+216,248
| +212% | +$25.6M | 0.01% | 1294 |
|
|
2020
Q4 | $12M | Buy |
101,948
+17,205
| +20% | +$2M | ﹤0.01% | 2402 |
|
|
2020
Q3 | $9.42M | Buy |
84,743
+43,780
| +107% | +$4.7M | ﹤0.01% | 2357 |
|
|
2020
Q2 | $4.19M | Buy |
40,963
+32,269
| +371% | +$3.45M | ﹤0.01% | 3338 |
|
|
2020
Q1 | $938K | Buy |
8,694
+1,848
| +27% | +$212K | ﹤0.01% | 5458 |
|
|
2019
Q4 | $797K | Sell |
6,846
-27,171
| -80% | -$3.15M | ﹤0.01% | 5997 |
|
|
2019
Q3 | $3.89M | Buy |
34,017
+30,692
| +923% | +$3.05M | ﹤0.01% | 3465 |
|
|
2019
Q2 | $317K | Sell |
3,325
-1,570
| -32% | -$148K | ﹤0.01% | 7506 |
|
|
2019
Q1 | $447K | Buy |
4,895
+1,089
| +29% | +$89.1K | ﹤0.01% | 6982 |
|
|
2018
Q4 | $289K | Sell |
3,806
-16,750
| -81% | -$1.23M | ﹤0.01% | 7340 |
|
|
2018
Q3 | $1.64M | Buy |
20,556
+3,663
| +22% | +$341K | ﹤0.01% | 4725 |
|
|
2018
Q2 | $1.68M | Buy |
16,893
+14,320
| +557% | +$1.24M | ﹤0.01% | 4375 |
|
|
2018
Q1 | $208K | Buy |
+2,573
| New | +$208K | ﹤0.01% | 7307 |
|
|
2017
Q1 | – | Sell |
-2,045
| Closed | -$219K | – | 8447 |
|
|
2016
Q4 | $220K | Sell |
2,045
-1,488
| -42% | -$174K | ﹤0.01% | 6172 |
|
|
2016
Q3 | $440K | Buy |
+3,533
| New | +$417K | ﹤0.01% | 5051 |
|
|
2015
Q3 | – | Sell |
-2,396
| Closed | -$276K | – | 9476 |
|
|
2015
Q2 | $276K | Sell |
2,396
-15,254
| -86% | -$1.6M | ﹤0.01% | 5877 |
|
|
2015
Q1 | $1.69M | Sell |
17,650
-5,786
| -25% | -$433K | ﹤0.01% | 3293 |
|
|
2014
Q4 | $1.58M | Buy |
23,436
+11,835
| +102% | +$733K | ﹤0.01% | 3191 |
|
|
2014
Q3 | $626K | Buy |
11,601
+916
| +9% | +$45.1K | ﹤0.01% | 4336 |
|
|
2014
Q2 | $475K | Sell |
10,685
-405
| -4% | -$16.5K | ﹤0.01% | 4468 |
|
|
2014
Q1 | $385K | Buy |
+11,090
| New | +$353K | ﹤0.01% | 4713 |
|
Citadel Advisors's CBPO Position: Q2 2021 in Review
Citadel Advisors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 318,196 shares — an estimated $37.7M sold.
Citadel Advisors first reported a position in CBPO in Q1 2014 and held it in 21 quarters. The position peaked at $37.7M in Q1 2021. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- Citadel Advisors reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- Citadel Advisors sold 318,196 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $37.7M.
- Citadel Advisors first reported a position in China Biologic Products Holdings, Inc. in Q1 2014 and held it in 21 quarters.
- Citadel Advisors's China Biologic Products Holdings, Inc. position peaked at $37.7M in Q1 2021.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.